Co-Authors
This is a "connection" page, showing publications co-authored by Guido Grassi and Claudio Borghi.
Connection Strength
0.613
-
Renin-Angiotensin System Inhibition in Cardiovascular Patients at the Time of COVID19: Much Ado for Nothing? A Statement of Activity from the Directors of the Board and the Scientific Directors of the Italian Society of Hypertension. High Blood Press Cardiovasc Prev. 2020 Apr; 27(2):105-108.
Score: 0.219
-
Correction: Gender differences in predictors of intensive care units admission among COVID-19 patients: The results of the SARS-RAS study of the Italian Society of Hypertension. PLoS One. 2021; 16(9):e0257181.
Score: 0.060
-
Preexisting Oral Anticoagulant Therapy Ameliorates Prognosis in Hospitalized COVID-19 Patients. Front Cardiovasc Med. 2021; 8:633878.
Score: 0.059
-
Determinants of healing among patients with coronavirus disease 2019: the results of the SARS-RAS study of the Italian Society of Hypertension. J Hypertens. 2021 02 01; 39(2):376-380.
Score: 0.058
-
Clinical Characteristics and Outcomes of Patients with COVID-19 Infection: The Results of the SARS-RAS Study of the Italian Society of Hypertension. High Blood Press Cardiovasc Prev. 2021 Jan; 28(1):5-11.
Score: 0.058
-
Gender differences in predictors of intensive care units admission among COVID-19 patients: The results of the SARS-RAS study of the Italian Society of Hypertension. PLoS One. 2020; 15(10):e0237297.
Score: 0.057
-
Age and Multimorbidity Predict Death Among COVID-19 Patients: Results of the SARS-RAS Study of the Italian Society of Hypertension. Hypertension. 2020 08; 76(2):366-372.
Score: 0.056
-
Personalized medicine-a modern approach for the diagnosis and management of hypertension. Clin Sci (Lond). 2017 Nov 15; 131(22):2671-2685.
Score: 0.046